Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Float Percentage Of Total Shares Outstanding: 0.00% (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNPHARMA Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
92 GF Score
Price ₹1,902.40
GF Value ₹1,954.01
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries Float Percentage Of Total Shares Outstanding?

Sun Pharmaceuticals Industries NSE:SUNPHARMA -0.08% 92 Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 22, 2026. GuruFocus rates NSE:SUNPHARMA with a GF Score™ of 92/100 and a GF Value™ of ₹1,954.01 (Fairly Valued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sun Pharmaceuticals Industries's float shares is 0.00 Mil. Sun Pharmaceuticals Industries's total shares outstanding is 2,399.33 Mil. Sun Pharmaceuticals Industries's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sun Pharmaceuticals Industries's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sun Pharmaceuticals Industries's Institutional Ownership is 23.74%.

NSE:SUNPHARMA
92GF Score
Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharmaceuticals Industries Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sun Pharmaceuticals Industries's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/2,399.33
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Aug. 22, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sun Pharmaceuticals Industries and its competitors.
Is Sun Pharmaceuticals Industries' Float Percentage Of Total Shares Outstanding too high?
Sun Pharmaceuticals Industries' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sun Pharmaceuticals Industries and its competitors. Sun Pharmaceuticals Industries's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (NSE:SUNPHARMA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,954.01, compared to a current price of ₹1,902.40 — trading 2.6% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Sun Pharmaceuticals Industries' overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (NSE:SUNPHARMA), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,902.40 is trading 2.6% below its estimated GF Value™ of ₹1,954.01. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for NSE:SUNPHARMA:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: ₹1,954.01 vs. price of ₹1,902.40 (2.6% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the NSE:SUNPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges 524715:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for NSE:SUNPHARMA

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,902.40
Price
₹1,954.01
GF Value